Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Healthy adults aged more than or equal to 18 years of either sex. <br/ >2. Written informed consent by participants. <br/ >3. The participant is resident of the study area and is willing to comply with study protocol requirements. <br/ >4. Healthy, as determined by medical history and physical examination. <br/ >5. Female participants of childbearing potential must have a negative urine pregnancy test within 24 hours prior to study vaccine administration.

1. Healthy adults aged more than or equal to 18 years of either sex. <br/ >2. Written informed consent by participants. <br/ >3. The participant is resident of the study area and is willing to comply with study protocol requirements. <br/ >4. Healthy, as determined by medical history and physical examination. <br/ >5. Female participants of childbearing potential must have a negative urine pregnancy test within 24 hours prior to study vaccine administration.

Nov. 13, 2021, 5:33 p.m. oms

Oct. 26, 2020, 8:29 a.m. oms

1. Healthy adults aged more than or equal to 18 years of either sex. <br/ >2. Written informed consent by participants. <br/ >3. The participant is resident of the study area and is willing to comply with study protocol requirements. <br/ >4. Healthy, as determined by medical history and physical examination. <br/ >5. Female participants of childbearing potential must have a negative urine pregnancy test within 24 hours prior to study vaccine administration.

1. Healthy adults aged more than or equal to 18 years of either sex. <br/ >2. Written informed consent by participants. <br/ >3. The participant is resident of the study area and is willing to comply with study protocol requirements. <br/ >4. Healthy, as determined by medical history and physical examination. <br/ >5. Female participants of childbearing potential must have a negative urine pregnancy test within 24 hours prior to study vaccine administration.